Dasotraline Completed Phase 1 Trials for Attention Deficit Hyperactivity Disorder (ADHD) / Binge Eating Disorder (BED) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02795637Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction